The University of Chicago Header Logo

Jessica Donington

Concepts (415)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
55
2023
1055
13.900
Why?
Lung Neoplasms
78
2023
2221
13.030
Why?
Pneumonectomy
23
2023
196
6.570
Why?
Neoplasm Staging
38
2023
1932
3.410
Why?
Thoracic Surgery
8
2022
41
3.410
Why?
Surgeons
6
2022
213
2.240
Why?
Osteopontin
6
2013
47
2.080
Why?
Radiosurgery
9
2021
272
1.830
Why?
Physicians, Women
5
2022
53
1.690
Why?
Thoracic Surgical Procedures
4
2022
42
1.670
Why?
Humans
131
2023
83765
1.570
Why?
Specialties, Surgical
2
2021
62
1.520
Why?
Thoracic Surgery, Video-Assisted
6
2022
30
1.450
Why?
Mesothelioma
14
2023
301
1.370
Why?
Adenocarcinoma
11
2016
1155
1.340
Why?
Early Detection of Cancer
4
2022
371
1.290
Why?
Pleural Neoplasms
11
2016
184
1.230
Why?
Small Cell Lung Carcinoma
4
2023
96
1.180
Why?
Esophagectomy
5
2009
81
1.150
Why?
Disease Management
3
2019
322
0.940
Why?
Neoadjuvant Therapy
7
2023
309
0.920
Why?
Catheter Ablation
6
2015
222
0.920
Why?
Chemotherapy, Adjuvant
6
2022
461
0.920
Why?
Jehovah's Witnesses
1
2022
18
0.910
Why?
Thymectomy
1
2022
29
0.910
Why?
Tomography, X-Ray Computed
11
2020
2496
0.910
Why?
Immunotherapy
6
2023
595
0.900
Why?
Radium
4
2023
7
0.860
Why?
Myasthenia Gravis
1
2022
80
0.860
Why?
Neoplasm Recurrence, Local
11
2023
1257
0.850
Why?
Biomarkers, Tumor
5
2021
1441
0.830
Why?
Symptom Assessment
1
2020
61
0.780
Why?
Antibody Formation
1
2020
169
0.770
Why?
Esophageal Neoplasms
4
2009
316
0.760
Why?
Antibodies, Viral
2
2021
293
0.750
Why?
Combined Modality Therapy
11
2022
1645
0.740
Why?
Surgical Flaps
3
2017
248
0.730
Why?
Societies, Medical
3
2020
573
0.720
Why?
Mass Screening
3
2022
609
0.710
Why?
Robotic Surgical Procedures
2
2022
261
0.700
Why?
Carcinoma, Squamous Cell
5
2016
1065
0.690
Why?
Treatment Outcome
14
2022
7776
0.680
Why?
Neoplasms, Second Primary
5
2016
250
0.660
Why?
Probability
1
2017
351
0.600
Why?
Salvage Therapy
2
2017
228
0.600
Why?
Skin Ulcer
1
2016
25
0.600
Why?
Female
44
2023
43674
0.600
Why?
Hyaluronan Receptors
2
2013
35
0.570
Why?
Frozen Sections
1
2015
47
0.560
Why?
Middle Aged
32
2023
24628
0.560
Why?
Male
39
2023
40172
0.560
Why?
Skin Transplantation
1
2016
172
0.560
Why?
Prognosis
16
2021
3618
0.550
Why?
Esophagus
2
2006
99
0.540
Why?
Monitoring, Intraoperative
1
2015
107
0.540
Why?
United States
14
2023
6421
0.530
Why?
Fluorodeoxyglucose F18
3
2012
129
0.510
Why?
Aged
26
2022
18030
0.500
Why?
Pancoast Syndrome
1
2013
2
0.500
Why?
Radiopharmaceuticals
3
2012
171
0.500
Why?
Fas Ligand Protein
1
2013
49
0.470
Why?
Positron-Emission Tomography
5
2013
309
0.460
Why?
Adult
27
2022
25194
0.450
Why?
Skin Neoplasms
1
2016
524
0.430
Why?
Fluorine Radioisotopes
1
2012
24
0.430
Why?
Radiation Injuries
2
2010
156
0.430
Why?
Cyclooxygenase 2
1
2012
98
0.430
Why?
Retrospective Studies
13
2023
8055
0.420
Why?
Neurosurgical Procedures
1
2013
207
0.410
Why?
Multimodal Imaging
1
2012
106
0.410
Why?
Bronchogenic Cyst
1
2010
5
0.410
Why?
Thoracic Wall
1
2010
22
0.400
Why?
Thoracic Diseases
1
2010
25
0.400
Why?
Soft Tissue Infections
1
2010
25
0.400
Why?
Clinical Trials as Topic
4
2020
1155
0.380
Why?
Risk Assessment
7
2022
2223
0.370
Why?
Simulation Training
2
2021
88
0.370
Why?
Radiotherapy, Adjuvant
3
2022
291
0.370
Why?
Survival Analysis
4
2019
1531
0.370
Why?
Education, Medical, Graduate
3
2020
358
0.360
Why?
Health Status Disparities
1
2011
163
0.340
Why?
Neoplasm Proteins
1
2012
533
0.330
Why?
Aged, 80 and over
15
2021
6422
0.310
Why?
Survival Rate
9
2021
1843
0.310
Why?
Healthcare Disparities
1
2011
347
0.290
Why?
Dumping Syndrome
1
2006
5
0.290
Why?
Gastric Emptying
1
2006
23
0.290
Why?
Protein Kinase Inhibitors
2
2022
586
0.280
Why?
Antineoplastic Agents
5
2020
2324
0.280
Why?
Transcription Factors
1
2013
1492
0.270
Why?
Stomach
1
2006
109
0.270
Why?
Esophageal Diseases
1
2005
25
0.270
Why?
Wounds, Nonpenetrating
1
2006
86
0.270
Why?
Patient Selection
3
2020
680
0.260
Why?
Pneumonia, Viral
2
2020
310
0.260
Why?
Patient Care Management
2
2020
31
0.260
Why?
Coronavirus Infections
2
2020
295
0.260
Why?
Deglutition Disorders
1
2006
105
0.260
Why?
Consensus
3
2021
309
0.260
Why?
Intubation, Intratracheal
1
2006
143
0.260
Why?
Computer Simulation
3
2021
1066
0.250
Why?
Gastroesophageal Reflux
1
2006
113
0.250
Why?
General Surgery
1
2007
230
0.250
Why?
Risk Factors
5
2022
5301
0.250
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2011
2390
0.250
Why?
Thymoma
1
2023
29
0.240
Why?
Antibodies, Neutralizing
2
2021
105
0.240
Why?
Hamartoma
1
2003
31
0.240
Why?
Thymus Neoplasms
1
2023
40
0.240
Why?
Negative-Pressure Wound Therapy
2
2014
10
0.240
Why?
Lymphatic Metastasis
4
2010
479
0.230
Why?
Medical Oncology
1
2007
347
0.230
Why?
Radiotherapy, Conformal
1
2023
88
0.230
Why?
Chylous Ascites
1
2022
6
0.230
Why?
Lung
4
2022
1124
0.230
Why?
Carcinoma, Bronchogenic
1
2002
30
0.230
Why?
Chylothorax
1
2022
7
0.230
Why?
Postoperative Complications
3
2022
2195
0.220
Why?
Neoplasm Metastasis
3
2019
1049
0.210
Why?
Loss of Function Mutation
1
2021
40
0.210
Why?
ErbB Receptors
2
2022
480
0.210
Why?
Steroids
1
2022
170
0.210
Why?
Funnel Chest
1
2021
6
0.210
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2021
104
0.210
Why?
Pneumothorax
2
2020
50
0.200
Why?
Lung Diseases
1
2003
259
0.200
Why?
Spike Glycoprotein, Coronavirus
1
2021
37
0.200
Why?
Chemoradiotherapy
2
2020
305
0.200
Why?
Immunization, Passive
1
2020
69
0.200
Why?
SEER Program
2
2011
183
0.190
Why?
Lung Transplantation
1
2022
173
0.190
Why?
Betacoronavirus
2
2020
253
0.190
Why?
Critical Pathways
1
2020
35
0.190
Why?
Pandemics
3
2021
693
0.190
Why?
Case-Control Studies
4
2013
1778
0.190
Why?
Sexual Harassment
1
2019
9
0.190
Why?
Riots
1
2019
1
0.180
Why?
Career Choice
1
2021
138
0.180
Why?
Clinical Decision-Making
2
2019
252
0.180
Why?
Protein Isoforms
2
2010
262
0.180
Why?
Drainage
1
2020
149
0.180
Why?
Nontuberculous Mycobacteria
1
2018
9
0.180
Why?
Sexism
1
2019
50
0.180
Why?
Randomized Controlled Trials as Topic
2
2020
825
0.170
Why?
Mycobacterium Infections, Nontuberculous
1
2018
24
0.170
Why?
Immunoglobulin G
1
2020
447
0.170
Why?
Thoracotomy
1
2018
57
0.170
Why?
Diagnosis, Differential
4
2013
1533
0.170
Why?
Respiratory System
1
2018
116
0.160
Why?
Drug Resistance, Neoplasm
1
2021
580
0.160
Why?
Periodicals as Topic
1
2020
166
0.160
Why?
Cohort Studies
5
2012
2699
0.160
Why?
Safety-net Providers
1
2018
36
0.160
Why?
Cost-Benefit Analysis
1
2020
439
0.160
Why?
Wound Closure Techniques
1
2017
14
0.160
Why?
Consolidation Chemotherapy
1
2017
21
0.160
Why?
Evidence-Based Medicine
2
2017
421
0.150
Why?
Thoracic Neoplasms
1
2017
61
0.150
Why?
Prosthesis-Related Infections
1
2017
57
0.150
Why?
Lymph Nodes
2
2011
527
0.150
Why?
Meta-Analysis as Topic
4
2016
86
0.140
Why?
Cell Proliferation
2
2013
1561
0.140
Why?
Asbestos
2
2012
22
0.140
Why?
National Cancer Institute (U.S.)
1
2015
71
0.140
Why?
Defibrillators, Implantable
1
2017
129
0.140
Why?
Biopsy
2
2016
1139
0.140
Why?
Surgical Wound Infection
1
2017
185
0.140
Why?
Forecasting
1
2016
308
0.140
Why?
Apoptosis
2
2013
1667
0.140
Why?
Subcutaneous Emphysema
1
2014
7
0.130
Why?
Photochemotherapy
1
1995
95
0.130
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2013
863
0.130
Why?
Simian virus 40
4
1998
35
0.130
Why?
Area Under Curve
2
2012
330
0.130
Why?
Prospective Studies
6
2023
4087
0.130
Why?
Liver Transplantation
1
2022
1239
0.130
Why?
Radiography
2
2014
799
0.120
Why?
Receptor, EphB2
1
2013
2
0.120
Why?
Neoplasm Invasiveness
2
2013
522
0.120
Why?
Peritoneum
1
2013
46
0.120
Why?
Snail Family Transcription Factors
1
2013
25
0.120
Why?
Neoplasm, Residual
2
2019
156
0.120
Why?
Microbiota
1
2018
365
0.120
Why?
Operative Time
1
2013
125
0.120
Why?
Clinical Protocols
1
2013
153
0.120
Why?
Surveys and Questionnaires
1
2021
2413
0.120
Why?
ROC Curve
2
2012
743
0.110
Why?
Blotting, Western
2
2013
773
0.110
Why?
Time-to-Treatment
1
2013
95
0.110
Why?
Epithelium
1
2013
311
0.110
Why?
Pain Management
1
2013
126
0.110
Why?
Cytokines
3
2022
754
0.110
Why?
Biomarkers
2
2016
1647
0.110
Why?
Extracellular Matrix Proteins
1
2012
121
0.110
Why?
Clinical Trials, Phase III as Topic
2
2007
165
0.110
Why?
Solitary Pulmonary Nodule
1
2013
137
0.110
Why?
Occupational Exposure
1
2012
79
0.110
Why?
Job Satisfaction
1
2012
73
0.110
Why?
Young Adult
5
2021
5839
0.110
Why?
Perfusion
2
2022
194
0.110
Why?
Palliative Care
1
2013
241
0.110
Why?
Radiotherapy, Computer-Assisted
1
2011
25
0.100
Why?
Carcinoma, Large Cell
1
2011
39
0.100
Why?
Sternoclavicular Joint
1
2010
2
0.100
Why?
Pulmonary Surgical Procedures
1
2010
8
0.100
Why?
Colony-Forming Units Assay
1
2010
40
0.100
Why?
Antibodies, Monoclonal
1
2017
1357
0.100
Why?
Cranial Irradiation
2
2020
36
0.100
Why?
Mutation
1
2022
3884
0.100
Why?
Cell Movement
2
2013
737
0.100
Why?
Ribonucleases
1
2011
92
0.100
Why?
Debridement
1
2010
57
0.100
Why?
Computer-Assisted Instruction
1
2011
43
0.100
Why?
Models, Anatomic
1
2011
88
0.100
Why?
Functional Laterality
1
2011
196
0.100
Why?
Oligonucleotide Array Sequence Analysis
2
2010
682
0.100
Why?
Tumor Cells, Cultured
3
2009
1030
0.100
Why?
Models, Cardiovascular
1
2011
96
0.100
Why?
Epithelial-Mesenchymal Transition
1
2010
68
0.100
Why?
Cell Line, Tumor
3
2011
2380
0.100
Why?
Tumor Burden
2
2011
278
0.100
Why?
Necrosis
1
2010
191
0.100
Why?
Joint Diseases
1
2010
48
0.100
Why?
Follow-Up Studies
4
2021
3603
0.100
Why?
Internship and Residency
1
2019
977
0.100
Why?
Tracheal Neoplasms
1
2009
8
0.090
Why?
Pain, Postoperative
1
2012
234
0.090
Why?
Glomus Tumor
1
2009
8
0.090
Why?
Opioid-Related Disorders
1
2012
149
0.090
Why?
Chest Pain
1
2009
37
0.090
Why?
Sarcoidosis
1
2010
67
0.090
Why?
Tuberculosis
1
2010
105
0.090
Why?
Minimally Invasive Surgical Procedures
1
2011
225
0.090
Why?
Cell Adhesion
1
2010
412
0.090
Why?
Endosonography
1
2010
95
0.090
Why?
Enzyme-Linked Immunosorbent Assay
1
2010
372
0.090
Why?
Length of Stay
2
2020
684
0.090
Why?
Mediastinal Neoplasms
2
2005
45
0.090
Why?
RNA, Messenger
2
2013
1943
0.080
Why?
MicroRNAs
2
2011
523
0.080
Why?
Time Factors
3
2012
5176
0.080
Why?
Wound Healing
1
2010
345
0.080
Why?
Microwaves
1
2008
28
0.080
Why?
Analgesics, Opioid
1
2012
397
0.080
Why?
Radiation Oncologists
2
2018
13
0.080
Why?
NF-kappa B
1
2011
432
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
387
0.080
Why?
Chest Tubes
2
2020
22
0.080
Why?
DNA, Viral
2
1998
263
0.080
Why?
Sex Factors
1
2011
1037
0.080
Why?
Receptor, IGF Type 1
2
1998
44
0.080
Why?
Neovascularization, Pathologic
1
2009
338
0.080
Why?
Gene Expression Profiling
2
2010
1355
0.080
Why?
Diagnostic Imaging
1
2011
455
0.080
Why?
Pulmonary Ventilation
1
2006
32
0.080
Why?
Cognition
1
2011
517
0.070
Why?
Sialoglycoproteins
1
2006
31
0.070
Why?
Carbonic Anhydrases
1
2006
14
0.070
Why?
Disease-Free Survival
2
2011
1203
0.070
Why?
Sex Distribution
1
2006
173
0.070
Why?
Mediastinoscopy
1
2005
5
0.070
Why?
Thoracic Injuries
1
2006
30
0.070
Why?
Peritoneal Neoplasms
2
1998
157
0.070
Why?
History, 21st Century
2
2017
174
0.070
Why?
California
1
2006
135
0.070
Why?
Hemangioendothelioma, Epithelioid
1
2005
9
0.070
Why?
Esophagoplasty
1
2005
10
0.070
Why?
Radiotherapy Dosage
1
2006
488
0.070
Why?
Anesthetics
1
2005
48
0.070
Why?
Blood Loss, Surgical
1
2005
111
0.070
Why?
Risk
1
2006
671
0.060
Why?
Antigens, Neoplasm
1
2006
319
0.060
Why?
Adolescent
3
2021
8806
0.060
Why?
Incidence
2
2022
1564
0.060
Why?
DNA Helicases
1
2023
76
0.060
Why?
Proto-Oncogene Proteins c-ret
1
2022
20
0.060
Why?
Preoperative Care
1
2005
393
0.060
Why?
Work-Life Balance
1
2022
6
0.060
Why?
Smoking
1
2006
600
0.050
Why?
Organ Preservation
1
2022
75
0.050
Why?
Asthma
1
2009
929
0.050
Why?
Adaptor Proteins, Signal Transducing
1
2023
300
0.050
Why?
Hospital Mortality
1
2003
342
0.050
Why?
Transfection
3
2011
882
0.050
Why?
Leukocytes
1
2022
200
0.050
Why?
Cross Reactions
1
2021
107
0.050
Why?
Oxygen
1
2006
721
0.050
Why?
Clinical Competence
2
2020
746
0.050
Why?
Antigens, Viral
1
2021
145
0.050
Why?
Immunity, Humoral
1
2021
65
0.050
Why?
Epitopes
1
2021
251
0.050
Why?
Child
2
2022
6705
0.050
Why?
Bioethics
1
2020
34
0.050
Why?
Etoposide
1
2020
193
0.050
Why?
Practice Guidelines as Topic
2
2018
1033
0.050
Why?
Risk Management
1
2020
44
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2023
437
0.050
Why?
Bias
1
2020
126
0.050
Why?
Margins of Excision
1
2019
37
0.050
Why?
Survivors
1
2021
217
0.050
Why?
Asbestosis
2
1998
5
0.050
Why?
Medicare
1
2022
364
0.050
Why?
Phosphoproteins
1
2021
252
0.050
Why?
Interdisciplinary Communication
1
2020
127
0.050
Why?
Tissue Donors
1
2022
442
0.040
Why?
Living Donors
1
2022
326
0.040
Why?
Sputum
1
2018
33
0.040
Why?
Infection Control
1
2020
114
0.040
Why?
Electrocardiography
1
2021
472
0.040
Why?
Bronchoalveolar Lavage Fluid
1
2018
120
0.040
Why?
Tumor Virus Infections
1
1998
81
0.040
Why?
Heart
1
2021
522
0.040
Why?
Genomics
1
2023
678
0.040
Why?
Oligonucleotides, Antisense
1
1998
68
0.040
Why?
Regulatory Sequences, Nucleic Acid
1
1998
144
0.040
Why?
Self Report
1
2019
277
0.040
Why?
RNA, Ribosomal, 16S
1
2018
236
0.040
Why?
Pilot Projects
2
2012
816
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
143
0.040
Why?
Liver
1
2022
1203
0.040
Why?
RNA, Antisense
1
1996
15
0.040
Why?
Feasibility Studies
2
1996
741
0.040
Why?
Chemotherapy, Cancer, Regional Perfusion
1
1996
10
0.040
Why?
Receptor, ErbB-2
1
2018
207
0.040
Why?
Sensitivity and Specificity
2
2012
1967
0.040
Why?
Comorbidity
1
2020
932
0.040
Why?
Protein-Tyrosine Kinases
1
2018
304
0.040
Why?
Proto-Oncogene Proteins c-met
1
2018
199
0.040
Why?
B-Lymphocytes
1
2021
712
0.040
Why?
Anniversaries and Special Events
1
2016
14
0.040
Why?
Heart Ventricles
1
2021
747
0.030
Why?
Papillomavirus Infections
1
1998
243
0.030
Why?
Chromosome Disorders
1
1995
114
0.030
Why?
Radiation Oncology
1
2017
124
0.030
Why?
National Institutes of Health (U.S.)
1
1995
111
0.030
Why?
Genes, Tumor Suppressor
1
1995
157
0.030
Why?
Base Sequence
2
1996
2312
0.030
Why?
Clinical Trials, Phase II as Topic
1
1995
173
0.030
Why?
Clinical Trials, Phase I as Topic
1
1995
150
0.030
Why?
Genetic Predisposition to Disease
1
2023
2225
0.030
Why?
History, 20th Century
1
2016
311
0.030
Why?
Proto-Oncogene Proteins
1
2018
650
0.030
Why?
Molecular Sequence Data
2
1996
3024
0.030
Why?
Chromosome Aberrations
1
1995
384
0.030
Why?
Genetic Testing
1
2018
515
0.030
Why?
Immunohistochemistry
1
2018
1736
0.030
Why?
DNA Damage
1
1995
359
0.030
Why?
Genetic Therapy
1
1995
340
0.030
Why?
Immunoenzyme Techniques
1
2013
300
0.030
Why?
Fluorescent Antibody Technique
1
2013
309
0.030
Why?
Pleural Effusion
1
2012
44
0.030
Why?
Pleural Effusion, Malignant
1
2012
14
0.030
Why?
Cricetinae
3
1998
558
0.030
Why?
Reactive Oxygen Species
1
1995
461
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2013
267
0.030
Why?
Tumor Necrosis Factor-alpha
1
1996
673
0.030
Why?
Fear
1
2012
67
0.030
Why?
Self Concept
1
2012
128
0.030
Why?
RNA, Small Interfering
1
2013
540
0.030
Why?
Recurrence
1
2014
1136
0.030
Why?
Thoracoscopes
1
2011
2
0.030
Why?
Surgical Staplers
1
2011
11
0.030
Why?
Radiography, Thoracic
1
2013
320
0.030
Why?
Taxoids
1
2011
129
0.030
Why?
Dissection
1
2011
42
0.030
Why?
Computer Graphics
1
2011
100
0.020
Why?
Community-Based Participatory Research
1
2010
35
0.020
Why?
Motor Skills
1
2011
69
0.020
Why?
Carboplatin
1
2011
286
0.020
Why?
Patient Positioning
1
2011
65
0.020
Why?
Kaplan-Meier Estimate
1
2012
854
0.020
Why?
Mediastinum
1
2010
46
0.020
Why?
Affect
1
2012
378
0.020
Why?
Multivariate Analysis
1
2012
988
0.020
Why?
Biopsy, Needle
1
2010
231
0.020
Why?
Down-Regulation
1
2011
502
0.020
Why?
Longitudinal Studies
1
2012
968
0.020
Why?
Depression
1
2012
443
0.020
Why?
Empyema
1
2008
10
0.020
Why?
Cells, Cultured
1
2013
2763
0.020
Why?
Gene Expression Regulation, Neoplastic
2
2006
1181
0.020
Why?
Plasmids
2
1998
279
0.020
Why?
Insulin-Like Growth Factor I
2
1998
114
0.020
Why?
Carbonic Anhydrase IX
1
2006
11
0.020
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
20
0.020
Why?
Regression Analysis
1
2007
596
0.020
Why?
Tracheal Diseases
1
2005
13
0.020
Why?
Lymphatic Diseases
1
2005
36
0.020
Why?
Age Factors
1
2010
1817
0.020
Why?
Polymerase Chain Reaction
2
1998
921
0.020
Why?
Predictive Value of Tests
1
2010
1636
0.020
Why?
Animals
4
1998
26003
0.020
Why?
Reproducibility of Results
1
2010
2649
0.010
Why?
Lymphoma, Non-Hodgkin
1
2005
259
0.010
Why?
Disease Progression
1
2007
1472
0.010
Why?
Gene Expression Regulation, Viral
1
1998
89
0.010
Why?
Virus Replication
1
1998
311
0.010
Why?
HSP70 Heat-Shock Proteins
1
1998
112
0.010
Why?
Oxygenators
1
1996
3
0.010
Why?
Carcinoma, Adenoid Cystic
1
1996
27
0.010
Why?
Sarcoma, Ewing
1
1996
42
0.010
Why?
Cardiac Output
1
1996
152
0.010
Why?
Hyperthermia, Induced
1
1996
54
0.010
Why?
Safety
1
1996
152
0.010
Why?
Cell Transformation, Neoplastic
1
1998
412
0.010
Why?
Cell Division
1
1996
692
0.010
Why?
Pulmonary Artery
1
1996
293
0.010
Why?
Remission Induction
1
1996
709
0.010
Why?
Sarcoma
1
1996
208
0.010
Why?
Interferon-gamma
1
1996
431
0.010
Why?
Melanoma
1
1996
443
0.010
Why?
Carcinoma, Renal Cell
1
1996
410
0.010
Why?
Transcription, Genetic
1
1996
1118
0.010
Why?
Blood Pressure
1
1996
1121
0.010
Why?
Rats
1
1996
3941
0.010
Why?
Donington's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (415)
Explore
_
Co-Authors (46)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_